grant

Delaying onset of nearsightedness trial Chairs grant

Organization UNIVERSITY OF HOUSTONLocation HOUSTON, UNITED STATESPosted 1 Aug 2025Deadline 31 Jul 2030
NIHUS FederalResearch GrantFY20250-11 years old21+ years old6-11 years oldAddressAdhesion PlaquesAdultAdult HumanAffectAgeAge of OnsetAsiaAtropineCell-Matrix Adherens JunctionsChildChild CareChild YouthChildren (0-21)Ching LoClinicClinical TrialsComplicationContact LensesDataDiminished VisionDiseaseDisorderDropsEducationEducational aspectsEnrollmentExhibitsEyeEye DropsEye diseasesEyeballEyedropsFocal AdhesionsFocal ContactsFutureGeneralized GrowthGlaucomaGoalsGrantGrowthHealthHigh PrevalenceIndividualInterventionJing LuoJingluoLow VisionMeasuresMechanicsMeridiansMethodsMyopiaNearsightednessOperative ProceduresOperative Surgical ProceduresParentsPartial SightParticipantPatient RecruitmentsPatientsPersonsPlacebosPopulationPrevalenceProbabilityProspective, cohort studyPublic HealthPublishingPuericultureQOLQuality of lifeRandomizedReduced VisionRefractive DisordersRefractive ErrorsReportingRetinal DetachmentRetinoscopyRiskRisk ReductionSchoolsShadow TestSham TreatmentSightSkiametriesSkiametrySkiascopySubnormal VisionSurgicalSurgical InterventionsSurgical ProcedureTestingTimeTissue GrowthUnited StatesVisionVision ScreeningVisualVisual impairmentadulthoodagesco-morbidco-morbiditycomorbiditycycloplegicdisorder of macula luteadisorder of macula of retinadl-Hyoscyamineenrolleye disordereye refraction disorderglaucomatoushigh riskimprovedinnovateinnovationinnovativekidslater in lifelater lifemacula abnormalitymacula lutea abnormalitymacular diseasemacular disordermaculopathymechanicmechanicalmiddle childhoodnear visionocular diseaseocular disorderontogenyophthalmopathyparentparticipant recruitmentplacebo grouppreventpreventingprimary end pointprimary endpointrandomisationrandomizationrandomized, clinical trialsrandomly assignedreduce riskreduce risksreduce that riskreduce the riskreduce these risksreduces riskreduces the riskreducing riskreducing the riskretina detachmentrisk-reducingsham groupsham therapyside effectsurgerytreatment groupvision impairmentvisual functionvisually impairedyoungster
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

Project Summary/Abstract
The prevalence of nearsightedness (myopia) is increasing worldwide, and so is the prevalence of high

myopia. Myopia, especially high myopia, is associated with reduced vision-related quality of life and sight-

threatening complications such as glaucoma, retinal detachment, and myopic maculopathy. Delaying the onset

of…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →
Delaying onset of nearsightedness trial Chairs grant — UNIVERSITY OF HOUSTON | UNITED STATES | Aug 2025 | Dev Procure